Lrp4 Mutations Alter Wnt/Beta-Catenin Signaling and Cause Limb and Kidney Malformations in Cenani-Lenz Syndrome

Yun Li,Barbara Pawlik,Nursel Elcioglu,Mona Aglan,Huelya Kayserili,Goekhan Yigit,Ferda Percin,Frances Goodman,Gudrun Nuernberg,Asim Cenani,Jill Urquhart,Boi-Dinh Chung,Samira Ismail,Khalda Amr,Ayca D. Aslanger,Christian Becker,Christian Netzer,Pete Scambler,Wafaa Eyaid,Hanan Hamamy,Jill Clayton-Smith,Raoul Hennekam,Peter Nuernberg,Joachim Herz,Samia A. Temtamy,Bernd Wollnik
DOI: https://doi.org/10.1016/j.ajhg.2010.03.004
2010-01-01
Abstract:Cenani-Lenz syndrome (CLS) is an autosomal-recessive congenital disorder affecting distal limb development. It is characterized mainly by syndactyly and/or oligodactyly and is now shown to be commonly associated with kidney anomalies. We used a homozygosity-mapping approach to map the CLS1 locus to chromosome 11p11.2-q13.1. By sequencing candidate genes, we identified recessive LRP4 mutations in 12 families with CLS. LRP4 belongs to the low-density lipoprotein (LDL) receptor-related proteins (LRPs), which are essential for various developmental processes. LRP4 is known to antagonize LRP6-mediated activation of canonical Wnt signaling, a function that is lost by the identified mutations. Our findings increase the spectrum of congenital anomalies associated with abnormal lipoprotein receptor-dependent signaling.
What problem does this paper attempt to address?